MAPT and Parkinson disease: Several proteins involved in neurodegenerative disorders such as Alzheimer's and Parkinson's disease, including Tau, APO-E, APO-D, A4, and SYUA, were observed to be increased by the treatment with both stimulants in ST for drug-treated relative to saline samples.